News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gallagher Cam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Gallagher Cam (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,242 shares
@ $26.3989, valued at
$244k
Sold 18,526 shares
@ $26.2079, valued at
$485.5k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/14/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,332 shares
@ $20.4244, valued at
$68.1k
Sold 8,501 shares
@ $19.9631, valued at
$169.7k
|
|
| 02/06/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,428 shares
@ $22.2213, valued at
$209.5k
Sold 572 shares
@ $23.0351, valued at
$13.2k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,500 shares
@ $24.1138, valued at
$229.1k
Sold 500 shares
@ $24.8672, valued at
$12.4k
|
|
| 01/06/2023 |
4
| Gallagher Cam (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Exercised (in-or-at-the-money) 1,574 options to buy
@ $0.0001, valued at
$0.2 |
|
| 01/05/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,700 shares
@ $21.0094, valued at
$203.8k
Sold 300 shares
@ $21.4567, valued at
$6.4k
|
|
| 11/15/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 11,600 shares
@ $22.72, valued at
$263.6k
Sold 900 shares
@ $23.479, valued at
$21.1k
|
|
| 11/08/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 12,343 shares
@ $23.6616, valued at
$292.1k
Sold 157 shares
@ $24.2374, valued at
$3.8k
Sold 12,374 shares
@ $23.5609, valued at
$291.5k
|
|
| 10/17/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $23.5103, valued at
$293.9k
|
|
| 10/07/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 7,004 shares
@ $21.9201, valued at
$153.5k
Sold 5,496 shares
@ $22.8308, valued at
$125.5k
Sold 10,000 shares
@ $22.618, valued at
$226.2k
|
|
| 09/16/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 8,426 shares
@ $25.1029, valued at
$211.5k
Sold 4,074 shares
@ $25.5866, valued at
$104.2k
Sold 8,866 shares
@ $24.3806, valued at
$216.2k
Sold 1,134 shares
@ $24.9898, valued at
$28.3k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 111,072 shares
@ $0
Granted 333,218 options to buy
@ $24.75, valued at
$8.2M
|
|
| 04/05/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 4,369 shares
@ $49.7153, valued at
$217.2k
Sold 3,335 shares
@ $50.6775, valued at
$169k
Sold 2,196 shares
@ $51.5861, valued at
$113.3k
Sold 100 shares
@ $52.7, valued at
$5.3k
|
|
| 03/16/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 4,578 shares
@ $41.4473, valued at
$189.7k
Sold 5,322 shares
@ $42.3107, valued at
$225.2k
Sold 100 shares
@ $43.18, valued at
$4.3k
|
|
| 03/08/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,477 shares
@ $44.9044, valued at
$425.6k
Sold 523 shares
@ $45.5607, valued at
$23.8k
|
|
| 02/15/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,264 shares
@ $51.2232, valued at
$167.2k
Sold 5,366 shares
@ $52.1529, valued at
$279.9k
Sold 1,370 shares
@ $52.737, valued at
$72.2k
|
|
| 02/14/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 8,203 shares
@ $0
Granted 7,595 shares
@ $0
Sold 2,079 shares
@ $50.1642, valued at
$104.3k
Sold 259 shares
@ $50.7472, valued at
$13.1k
Sold 4,850 shares
@ $50.1732, valued at
$243.3k
Granted 19,245 options to buy
@ $52.61, valued at
$1M
|
|
| 02/07/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,290 shares
@ $52.7717, valued at
$120.8k
Sold 6,460 shares
@ $53.5118, valued at
$345.7k
Sold 1,250 shares
@ $54.3524, valued at
$67.9k
|
|
| 01/19/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,434 shares
@ $61.7066, valued at
$211.9k
Sold 3,424 shares
@ $62.367, valued at
$213.5k
Sold 1,842 shares
@ $63.4466, valued at
$116.9k
Sold 1,300 shares
@ $64.6631, valued at
$84.1k
|
|
| 01/05/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,397 shares
@ $73.1779, valued at
$175.4k
Sold 900 shares
@ $73.9156, valued at
$66.5k
Sold 700 shares
@ $75.3214, valued at
$52.7k
Sold 3,641 shares
@ $76.0255, valued at
$276.8k
Sold 1,106 shares
@ $76.9026, valued at
$85.1k
Sold 1,156 shares
@ $78.2444, valued at
$90.5k
Sold 100 shares
@ $78.91, valued at
$7.9k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 6,614 shares
@ $75.0215, valued at
$496.2k
Sold 2,400 shares
@ $75.7637, valued at
$181.8k
Sold 986 shares
@ $76.6673, valued at
$75.6k
|
|
| 11/05/2021 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,506 shares
@ $82.0933, valued at
$205.7k
Sold 5,094 shares
@ $82.9758, valued at
$422.7k
Sold 2,400 shares
@ $83.786, valued at
$201.1k
|
|
| 10/04/2021 |
4
| Gallagher Cam (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 1,900 shares
@ $64.7058, valued at
$122.9k
Sold 2,664 shares
@ $65.7722, valued at
$175.2k
Sold 4,820 shares
@ $66.7697, valued at
$321.8k
Sold 616 shares
@ $67.3724, valued at
$41.5k
|
|
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|